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Ven ieallr.lOsmission Or HIV is responsible for 90% of oil AIDS cases in children <13 years of age (I). E.1ch year nbout 7000 HI V· infected women in the United States give birth 10 live infonts. exposing their children to potential disease. This ri~k of verticol transmission of the vi rus has been reponed as 10% to 50%. with most ofthl.' larger studies in the United States and Europe suggesting rates of 25% to 35% (2) . The efficacy of a.l.idOlhymidine (AZT) in red ucing the risk of nmtemal·fetal lnlnsmission was demonstraled ill a published s1Udy from a natiol1-wide clinical trial sponsored by the Nalional Institutes of Heo llh (3) . Wo men in the second or third trimester of pregnancy received AZT at a dose of 100 mg omlly 5 times daily (the equivolent of 8.5 mglkglday for a 59-kg womon): during labor they received AZT intravenously . fi rst at 2 mglkg body weight for I hour and then at I mglkg until delivery. Their infanL~ received AZT orally al 2 mglkg every 6 hours for 6 weeks .. ner bin h. The regimen produced a stati stically significant 67.5% rela· tive reduction in perinatal transmission of I-I IV . Toxie effects of the drug were minimal. and few women discontinued AZT treatment. Although the infants' hemo· J. C. HA IT AL globin concentra tions were loignifi c:mtl y lower at birth for the AZT group than for the placebo group. the values were si milar for bOlh groups by 12 weeks of age. A significant reduction in vert ic:II transmi~~ion of H[ V was also obtained in a si mihlf ~Iud y in which women received 500 mglday AZT in mid 10 late pregnancy (4). Because of these fin dings, the U.S. Public Health Service has recommended that an AZT regi men be pres(;ribcd for all !-II V-infected pregnant women who have had no previous exposure \0 AU and are at > I.J weeks of gestation.
AZT i~ not yet recommended. however. for women who are in their fi rst trimester of pregnancy. and only min imal da ta are a' ailable from women who l>larted AZT treatment before conception und con ti nued therapy throughout pregnancy (5) (6) (7) (8) (9) . No teratogenic ahnoflnal ities or pattern of hematologic toxicity in tile newborn:-were repon ed by these investigators. Findings fro m the Antirctroviml Pregnancy Registry. established by the WcJJcome Foundation in conjunction with the Centers for Di~ca.sc Control and Prevention. indicate that the pot~ntial teratogenicity of AZT administration in the first trimester. that is. 2St. doe~ not differ from the expected proponion of 3'K in the g~n e ral population (10) . In mbbi ts and rats. AZT hus ~h ow n lillie toxicity to th~ devel· oping fetu s whe n lIdmini .. tered during pregnancy (11). Mice [hm received oral AZT at 10 10 300 mglkglday from day 1 postcoiturn Ihrough all or plm of gestation did not dIffer rrorn conlrol .. in the num ber of rcsorptions or fetal malformations ( 12) . However. ;mother :-tudy reported fewer pregnaneic ... fcw~r healthy felusc, per 11l0U'iC. and a greater number of re-.orplions when mice were treated with AZT at 0.25 mglml (-1 7.6 mglkglda y) beginning 6 week.-, befon: mating (13) . T he in\'e.~t ig[lIors ~ugge"ted that AZT expo .. ure in early gesw.tton res ulted in pregnancy failure rather Ihan feta l malfonmllion. Finfl lly. in a 'Iudy by re~earc h e r~ at the Nmionfll Cancer In .. titute. the offspri ng or pregnant mice expo:.ed to high do.'>es of AZT (close to the max imum dose allowing fctal via bility) developed liver. lung. and reproducti\c organ tUlllo rll at ral c~ ~ver<l l ·fold hi gher Ihanthose of control .... n.;; reported in Ihe Sell/lit' Times. Wednesdny. January 15. 1997 (p. AS). Offspring of fenm les exposed [0 doses approximating human clinical u.ses did not dcyelop tumors.
Owing to differcnce~ in drug admi ni.stmlion und met:lboli srn, tile absence or pre~cllce of temtogcnie effects in rode nts nw y not adequately predict teratogenic e ffects in humans. Before AZT can be recommended for women in the fi rs t trime"ler, fldditi onal studic .. in u repre~en lative animul modcl should be dOlle. The pigtailed 111Ilc:lque ( M lIcaC:lIl11!IIIt'.wrillu) is un ideal experimc ntal animal for this purpose. Phnnnacoki nctic da ta indicate Ihm AZT cro .. ses the macaque plucelll:t passively. as it docs in humans. and exhibits a ~il1l i1 ar metabolic profile (14). In Ihi~ study. we investigated the toxicity of AZT in pigtuBed mflcaque infant.s that were exposed to the drug over the entire gestational period. AZT was udmini~te red to fema1ellthat were nei ther infected nor receiving drug .. of abuse. The siudy environment was well controlled. find non-AZT-exposed animals underwent concurrent testing identical to that of [he test animals. Preliminary results of thill study have been presented ( 15). and the focu,> of this paper is [0 repon our conclusions on the IOxicity of AZT exposure in pregna11l pigtailed macaques and their offspring. .cl-cral su'·ce,"'I'C, normal nl\!n~trual ey,·le,. they "eN' "lTllically im· ptnnlc.! wilh " !!:"Inc catheter while under halnlharlC :mcstne,IJ. lllCY ,,~re tN'IIh!d (lQ'Wpcr.II"·ely "lIh Jnalj!esl(''' and 1Il1o"etl HI R-.;over lrom surger) hcforc treatment bcj!J.n. Afler begllln,ng In:almCni. all anmlals "ere nMled "'Ilh Ihc .~me male beglnl1ing un nooullI:l)' 12 oflhc "te!l'lru~1 cycle. OVUIOIIOIl wa~ II~WlIlCd 10 ha\'C o.:currcll wh.:" thc anim~l'~ ~J.ual '~nl hCl1ml 10 dc'lulno:Si:e (171: Ilk: firM dJ) uf dcIIlHte..ctnec: "3.' eOIl'>Iden:d lIay I of thi' rotcnlt:d rn:gnanC). I"n:~nJ.n~) "-:lO' Icnfitd b~ UhrIhoor><l ~x~mi· nation on du) 30: fcla] \ i"hilil~ ami gro"th ,,~,e u<;<c<;.'-C.! u~lIlg ullm· sutmd ~t ,JaY' 40. SO. 60. 8{J. 100. 120. 140. uml 160. IteJd are". hil'~nClal di~"I1K:e. femur ICIl!;lh. amlthe rJtiu Ilf !lead eircumfcn:oce to abiJOlllinal " in.;umfcn:nce "cre 1IK·a"Ured by I~ method., of Conrud ~l ai, ! 18]. Who:'n 11O"it>le. t to 2 ml of amlllQlic iluid was ~otll'Cled on ,J:,y~ SO, ~O. 120. and 160 for dCICrnlinaliOIl of AZT conccntnIIlOll_, All ~ml!TQI annll~,]' w.::re handled ~nl1ilarly to AZT. lrN,!ed ~ubjccts for aJl pr,)i!edure'. tf :111 :ulimat was not fQund 10 bc p"'g!1anl ttl lIte 3()-da~ ullra;;ound num;n,,!ion. it L'OIllinued IU reedl'e In:atmenl and "as relnaied in ih .lCli llK'nMNal cycle.
METHODS

AI'T (I
Blood "a, ~ulleclcd b) tCl11or.,1 verupullclUn: for complel': I,tood count (C BC). c"nj .. '~1 ehemhtry all'ltysi~. and crYlhropuietin (EPO) before e"lhctcrizalion . .:II 2 and" weels of 11'"ulnlCllt. and then CI"I)'.j "l-':Jt.. One was placed in sterile 2~,f EDTA disodium ~alt (Sigma Ch~mical COllljMII)') in baetcnostallc 0.9'1, sodium chiorilll: (Abholl Labur.do--ric ... Nonlt Chicago. 11 •. U.S.A.); thl-other was placed in 1000 US!' Vlml of prc,erv:lti\'e-free heparin (mallufaclured for Marsam P!ulrm.leeuileals. Inc" Cherry Hill. NJ, by E,R_ Squibb & Sons. Inc .. Prince\Qn. NJ. U_S.A.). An additional blood ,amllie fUl cac ~"'! dinic~1 c!>om-ISiry anal),i~ \\as taJ.:en \\hlle thi: infanl was unlll:r kCI:lrnine aneslhesia (5-10 mglkg 1r.1). Further CBCs and clinical chi'lI1i.tries \\ere obtained from aw~ke infalll~ at 2 ,,"eel) of age, and then cI'ery 4 weeL. ur1l11 -10 IllOnth) of age. Scm for bPO measun:ments "ere collecled witllin Ihe lin.l \\eel. at 2 \\'eels, IlIld at 26 \\'ech. l1tc CBC. EDTA marrow u~pir.i1e. ~rum chcm;strie'. and EPO -amples "ere pl'Ol:t's-ed II-~ .le-)Crit>Cd p~violl~ly for adulb. All ",~ay,\ were performed by Ihe Pl\oe-ni~ Cenll1l1 LabomtOl) .
l1tc frcquern:ies of pr~ellllor l"ClI~ IINC a,,-,,yed from the hepannlI.ed m;lrrow a~pinlle . For tIw:,<t ,lUdic,. marro\\ 1T1OI1000ucJear cdt. Dire':lly after bIrth. ,nfants were -.eparateJ from lheir daJm; and placed In holcUc-s ill Ihe nu~ry of the Infant Prun:ll" Re\oC arch Laboratory (IPRL). wocre they received 24-hour inlellsil'c .·arc. Ollce Ihe) \\'Cre temper~lure-reglllatin8 (-2 wecl. of age), tile) lien: u"~n,fcrred 10 illdil idual cllges III a general inf3n1 hou"ng area. There they up:-ricneed the ~hln dard housilll!:. fc,'([ing. and bi::h!lvioml ie'ling uo;cd in lhe IPRL (20) . All infull t~ were provided wilh similar " j,ual. ullditory. oIfaclory. and luctile ~lil11ulation in thcir horne cages. rncludln~ surmgales (clO1h diapers) until 140 days of age. lind daily. 3O'rninUle '</-cilllizalion willt 3n ullChanglllg group of non-AZT -<"po,;ed animal, of tlte »lime specie,.
The infanl_ \\ere Ifk'nllomd daily by lhe full.t unc I'eterinary staff. and compuleril.ct.I medical records allowed cOInpariSOlh of clrnieal treatment rerords by Ite!llmCI\t group. Each infant was wcighetl wcckly. ;lnd weight increa.ws over ti ll"IC b)' lreatment group were compared. Co!:nnl\e and bchaviordl dC\"dopn>ent Wa." M:;e,sed by measurement of neon~talll."flexes. perfnmtance OIl 11:51$ of obJ«1 pemtanence. and perforrndnce on lhe W;\.Consin Geneml Te~ting AppWllIUS (WGTA\ Tc.~len. W('I\' blind to IremrnCIII gruup.
Te,tcd refle:>.1:5 inclutlcd rooting (Iefl Jnd righl), ,pouting. gr~~ping IleO hand and lOot). I isual Ofrenlalion. ~n(] \'i~ual l t':lC'lil1g (or both lIt'ar :100 far <," nult . Te<ting took phll'c clery other day from bllth to 2 weekS of ~gc. uml agc :It flr.1 du) of ~trul1gC't re.'pon,e wu~ I\'corued UO.21l.
Objcct pcrnllll'lClJ<."C-lhe conctptu~li/.alron Ihal objecb COUlrnuc 10 n i~t ev~n "hen they are not in .ighl-wlI!i It)t~'([ In a manner similar to that used Willt ltuman inr:lI1ts (22). 'I1tc infant was held by Olne IC,lcr while another tester prc",ntcd one of fool' tasl,. Innially infpnls were omcl'"\ed for their ~bility 10 reach (Of. gr~sp. and pick up an ' ' ' ' JCC' in pluin vic" (viwally direcled reach ing). 11k': <;«:t)nd and Iltrrd tasli required that the illfJnt pick up lin ''''je'."1 Ihal wa~ partially or comrlclel~ ltidden. The IllS! t .... k re'luired retr;ev:l1 ofth.ro hirlden nhJect from one of 1\\0 identical \\·ells. In ellCh lask. infant& observed lhe leSter hidlllg the objeCi and had I S seconds 10 ll!"POfld. Cnlenon WI!> 8 of 10 correct fC"pon..c' for a ~Jl<.'Cifie tJsl-. ovcr 2 te~lIng days. Te'llOg look place J li nt.e~ a week from 2 wceh of alOe unlil cornp\ction of all ta~b. 1\lle at criterion for each tasl "as Rnalyud for difr('fcnccs bet\\'een trealment ,roups.
1lkc WGT A t eaming 'cries W.I~ pcrfonncd.j days/\\ec l h<:I\\ecn 4 Jnd 6 1lH)!1lh, of age. The appamtu, conlained a ~mall c~gc for-IIll' 11m mal and an opaque <hdmll door to hiLk m~n;pulation of object:. 11) lhe eAptrinlCnter. l1tc..c lIS<C'SnlC!nh cltallenged the infant wilh lin 
RESULTS
Founce n animals wcre mated a total of 41 mcnqrual cyclcs (29 AZT. 12 control). rcsulting in 20 pregnancics in 10 animals (12 AZT, 8 control). Four an imals nevcr conccivcd. Fivc animals conceived more tha n oncc (4 Iwice. I Ihrice). participating in both control und AZT group!'. Each animal was allowed to regain baseli nc hematologic par.lJ11eICr<i before being assigncd to anothcr study group. Sixteen pregnancies were carried (Q teml (9 pregnancies in 9 AZT females and 7 pregn;mcle\ in 6 con trol females). In conlraSI 10 our preliminary observations (15)" !.he numbers of eonceplions achieved und pregnancics brought to term were nOI statistically different betwccn AZT-treatcd and ("'onlTol animals (I' > .05).
The four pregnancies that were not carried to len11 (3 AZT. I control) were. discovered to be nonviable wilhin thc first 40 days of gestation (normal gestation for M. lIemestr;lI(/ = 172 da ys). In the control prcgnancy. Ihe darn was recathctcrized at 35 days of gestation and subsequcnlly lost hcr fetus. T\\o of the AZT-exposcd fetuses nevcr appeared viuble by uhrasound and wcre resorbed. The Ihird AZT-exposcd fetus was lost when Ihe dam becamc ill and died. This anim31 had 10M 15% of it~ b:t'iClinc body wcight at 31 days of AZT trC3tment and died at 41 days of AZT treatm!!n\. P:lIhologic findings revcalcd hepatocellul ar atrophy and lesions con<;i\tcnl with a toxic etiology.
Tocolytic drugs wcre adminbtercd to 5 dams (4 AZT. I control) for 6 to 17 days beginning al around 140 days or pregnancy. All 5 pregnancies re~uhed in viable binhs wi!.h gcslationul agcs between 156 and 172 days.
Of the 16 tc rm pregnancies" 6 were dcl ivered by Ct!-sarean scction (4 AZT" 2 control). Two of thesc infants were stillborn (I from cach treatmcnt group). The fetus of Ihe control dum had the umbilical cord wrapped 4 timcs around its wai~1 and probably died during attc mpted \'nginal delivcry. The AZT-exposcd fetus wa~ diagno.\lcd with hydrops fetal i~ al Ihe 160-dny u1tr:t~o und examination and died during {'c\arcan section 2 d ay~ later. The dam exhihited polyhydramnio~. but no sig.ns of preeclampsia or diabetes. TIlc fetus had scvc rc a.nemia (hc matocrit 12%) and severe gcner:l li zcd edema. It also had an appi.lrcnl lack of bone marrow cellularity, a marked reduction of lymphocYlcs in thc spleen. and vascul ar mincralization in the brolin. A clinical c het1li~try analyzed from blood collected by cardiac punct ure wilhin 15 11Iinute~ aftcr delivcry indicatcd norlllal newborn valucs for blood ure:! nilrogen (BUN) level s. crcatinine. and bilirubin nnd towcr than norm:tl valucs for tOlal protein (3.4 gAil). albumin ( 1.9 gldt). and alkaline phosphatasc (149 lUlL). In i.I subscqucnt conlrol pregnancy, the d:tm carried a healthy in fant to leml .
Placcntal ti~su c was collected from 12 of the tc rm pregnancics (6 AZT. 6 control). Upon gross eX:lmin:lIiol1. on ly the placcnta from thc dam of the hydropic fetus wns unusual. The two lobes were fuscd and markedly cdcmatous wi th many t1uid-fillcd cysts. On exami nation by light microscopy. only I AZT-cxposcd plaCCl1l~l was ab-nom1al. exhibiting acute amnionltis. funl l>iti~. and a large infarct. This dam was 011 tocoly~is for 6 days and delivered a health) infant at 172 days of ge~lation . All other AZT-exposcd and all control pl:lcentas were similar to those collected from II RPRC Colony pigtailed macaques matched for matemal :lgc and weight. parit y of thc dam. and ge .... tational age at time of delivery. One AZT animal had a sing le-lobed pl:lceilla. All other AZT animals and all contro l animllis had double-lobed placentas.
Placental lobe weights fo r .. AZT and 4 control lInimals wcre avai lnblc for comparison with tho~e from the II colony animals. The placentu from the hydropic felal pregnilllcy was not u~ed for co mparison~. Lobe weights for a given pregnancy were combined. Mean placental weight for the AZT group wa~ M 1.4 ± 22.4 g. versu~ 126.8 ± 22.5 g for the control group (p = .029) and 111.2 ± 22.5 g for 1he colony anim:ll~ (p = .o.t I). TIlese differencc1<o wcre qalbt ically ~i gn ifi eant. No differe nce was found in the mcan placental weight.~ of the control and colony groups. nor did gestatio nal age. gender of fetus. or mode of delivery (ccsarcan section ve r~u 1<o vaginal) have an effeC1 on mean placental weigh1s in either group.
Inc luded in the previous an:llyses wa~ 1he AZTeX l>osed placenta tllltt was found 10 be ab normal by ligh1 microscopy. Bec:lu~e this 1i s~ue \Va~ n01 recovered immediately 3fter delivery. it~ longer expo!.ure 10 ambient room 1ernpcraIUre I1Uty havc resul ted in all inaccura1e weigh1 assessment . When the comparisons between groups excl uded thi:. animal" l> data. no l>tati5tical differences were found be1ween corurol and AZT animal~ (p = .052). or be1ween AZT and colony animal~ (1' = . 187). Li~ewise. no s1a 1 i~tica lJ y ,ignifican1 difference obt.tined between grou p .. in mtio of placent.tl we ight to infant birth weight whether the abnormal AZT tissue waoS included or excl uded (I':> .05).
Individual AZT peak pla<.,ma concentra t ion~ and plasma conccntration-time curves varied considerably between animab during the 9 tcrm pregllanc ic ... Mean peak pla~lI1a concentrations. however. did not differ .. ignificantl y with pregnancy (nonpregnant. 329. 1 :t 98.8 ng/ml: second trimester, 357.2 ± 99. 1 ng/ml: third trimester. 352.6 ± 135.8 nglml; p :> .05) (Fig. I) . Area under the concentration-time curve (AUC) was estimllted from time 30 minutes 10 4 hour~ afler an AZT dose (LAGRAN: C. Edi ss. Universi ty of AIt)C11a. Edmonton.
Alberta. Canada). Mean AUC was nOI st:ltistic:ltly difrerent fro m AUC~ in the second and third trill1csle~ (nonpregnant. 580.2:t 136.3 ng*hr/ml : second trimcster. 668.8 :t 137.4 ng*hr/ml: 1hird trime,ter. 657.1 ± 267.1 ng *l1/ml ). IncTCast.:d AZT concctl1rntion in amniotic nuid was .\teen in 1he 9 AZT-P fe m a l e~ over time: 1he change was ~i gnific:ltl1 (p < .01) betwccn 1he second and third sampling periods (115 + 9.7 nglml at 80 day~ of ge~t:ltion versus 190:t 17.6 nglml at 120 days of gestation). By 1he fO Ullh ~;unpli n g time ( 160 da ys of gel>1'l1ion). the concentra tion had increa~ed 10225 :t 25.0 nglml. The time of the amniocente1<ois from the la.\tt administered AZT dose was nOI a ~ign ifi cllnt covariate. One extraordinarily high da1a point W:lS e.xcluded from 1he analy')cs: (Ill AZT concentration of 3509.5 ngJml in onc al1iuml'" amn iotic ~a mpl e at 114 days of gestation. No sub1<oequenl ~a11lpling. of amniotic flu id was possible during thi~ pregna ncy. A healtl1y infant was delivered vaginally al 179 dllYS of ge~ta tio n . At 2 d ay~ of age the infan1 had a hematocrit of 36% and a hemoglobin of 11 .9 gldl. Bilirubin at 2 days of age was 5. 1 mglday. 1he highes1 l>ost na1al bilirubin value of any AZT-expol>Cd infant in th i~ study. Plasma from the infant at 4 days of 'Ige contained a mC:lsurable quanti1Y of AZT (27.5 nglml) .
No effects of 1rclltmCnt wcrc reflected in the amount of weight gained during pregnancy. Menn body weight was 7.5 :t 1.7 kg for CONT-P anima ls and 7.1 :t 1.6 kg for AZT-P animals. The mean body weight of AZT-NP animals (6.3 ± 0.8 kg) was not significnntly different from ba ... c1 ine (6.8 ± 1.1 kg).
AZT signilicantly affccted hematocrit und bemoglobin levels in bolh AZT-P and AZT-NP animals compared wi th CONT-P animul't (Table I ). An abrupt decreasc in Icvch of hemlllocri t and hemoglobin was apparent in all :mirnals at 2 \\Ieeh of AZT therapy. Lc\'el~ rellched nadir b) 4 week:. of treatment in mo~t AZT an ima". then To further ex amine the hematologic toxicity descri bed previously. we di vided the AZT-P :md AZT-NP females into two subsets: animal s that became severely anemic (hemoglobin <8 gldl) and tho!.C that became moderately anemic (hemoglobi n 8-10 gldl) during the fi rst month of AZT treatment. Several parame te r, \\ere examined: " itsclinc he moglobin values and mlllemal weights lor the two ~ub se lS . percentages of decline in hemoglobin and weight after 4 weeks of AZT, lind pregnancy status after 4 weeks of AZT. The difference was significant between the twO ~u bsc t,\o not onl y in buseline hemoglobin value .. but al so in the percentage of decline during the fi rst 4 weeks of AZT tre:ltment. Mean baseline he moglobin values were 1O,6::t: 0.6 gldl for the severe anemi a subset and 11.7 ± 0.9 gldl for the moderate anemia subset (p = .01 9). After 4 weeks of AZT treatment, the mean percentage of hemoglobin decline WlI, 32.4% ± 6, SlJt for the severely anemic unimals and 23.9% :: 4 .2~ for the moderately anemic animals (p = .017). No statistical diffe rences were found in baseline weight (6.6:: 1.0 kg for the severel y anemic <;ubset ver!.us 6.S ± l.l kg for the moderately anemic subset) or in percentage of weight lost in the first 4 week,,, of AZT thera py (9.4% ± 7,5% versus 5.9% ± 5. 0~; p > ,05). TIlCrefo rc. he:lvier o r lighter animals weTC not more sevcrely affected by AZT treatmenL Pregnancy status was also not a <;ignificant covariate, Both pregnant and nonpregnant animuls were represented in each group. and prcgnanlllnimab did not suffer a greater pcrcenlltge of decline in hemoglobin in the 4 weeks of trcutmen\.
Red-ce ll meHn corpu scular volume ( MCV ) increased progressively while the animals \\ e re on AZT therapy, and pregnancy had a ~mall additive effcct. Some animal, reached maximum MeV much curlier on AZT treatment than othcrs (range at peak MCV, 39-258 days of treatment), and MCV values in all animals remained elevated for the remainder of treatment. In animals that werc on AZT thernpy for > I 0 weeks, mean maximum MCV allained was 7 1.6 ± 5.04 fl (1/ = 3 AZT-N P: 11 = 9 AZT. P). MCV was not elcvated in CONT-P animals.
Scrum EPO concentmtions we re thc same in CONT-P and AZT· P dams at baseli ne. After begi nni ng treatment. however. AZT·P animals had elevatcd serum EPO levels throughout administration of AZT (p < .05; Fig. 3 ). This level increased with declining hematocrit values. al· though thecorrclation wa~ not inversely proportional. No ,ignificant differences were fou nd between the slopes of the 1ine~ for the two groups. although the y.interccpt for the AZT·P group was significantly different from that of baselinc or the CONT·P group (1' < .05; data not shown).
AZT treatment had sign ificant effects on total lekocyte counL and pregnancy caused a further decrease in these counts ( Table I) and AZT-exposed (AZT-P) dams. over a JO·month treatment period. Despite the AZT· related reduction in leul.ocyle levels, no AZT 11l1imal had a tolal Icul.ocyte count <1500 cell'lrmn ' .
Absolute lymphocyte coum (ALC) was significam ly reduced by pregnancy, but AZT tremment had no addi· tional effect. No statistical differences were found be· tween baseli ne and AZT·NP valucs. AZT administr..ttion, however, significantly decreased absolu te ncutrophil count (ANC) in pregnant animals. In contrast. pregnancy increased ANC in CONT·P animals. No statistical differences were found between baseline and AZT·N P values. One animal had Inll1sicnt neutropenia . with courllS of 700 and 936 cells/mm 3 • respectively. at 62 and 140 days of AZT treatment: :J count of <750 cel1vmm 3 indio cates severe neutropenia. Platelets increllsecl significantly wit h AZT thcnlpy; maximum levels were reached by 8 weeks in AZT-P dams and by 12 weeks in AZT~NP an imals. Platelets decreased ~omewha t duri ng the remainder of AZT trcm· ment. but re mai ned dev,lIcd over ba~cli n e in both AZT groups. Platelet levels werc unchanged th roughout water treatment in CONT· P dams. Marrow as pirntes were examined at baseline and after 60 to 129 days of pregnancy. Mean val ues for thc per· ccntages of erythroid cell s were 41 for AZT animals (II = 8: range. 20%-75lk) and 37 for l'ontrol animals (/I = 6: mng!!. 171k-50%): differencc~ were not significant. Megaloblastic erythropoiesis was not evide nt according to standard morphologic criteria. No significant elevations over baseline Ic\'cls wcre seen in :lIly treatment group for BUN. creatinine, bilirubin. alani ne ,u l1inotran~ferase CA L T), or aspartate: aminotmllsferllsc (AST).
Fourtecn live·bom infants (6 control, 8 AZT·exposcd) and 2 full· term stilll)orn inf:l1lt, (I control. I AZTexposed) were studied for cIT!!Cb of AZT exposure in utl!fO. Henwtocrit values 24 hours aftcr birth W!!TC not ~ignificantly di fferen t bctv,.een groups: AZT -exposed (/I = 7; 50.5 ± 9.5: range, 35.0~.0'l) and control (/I = 6; 57.0 ± 6.9: rnnge, 43.5%-63.0%). One week after birth. howcver. hemoglobin Hnd hematocrit vfllues were <;tatistically lower in the AZT·exposed infants than in the control infants (hemoglobin 13.1 ± 2.3 gldl and 16.9 ± 1.0 gldJ. re:.pectivcJy; hematocrit 38.9% ± 6.1% ilnd 50.9% ± 2.3%, respectivcly). Levels of these two eryt h· rocyte panllnclen. continued 10 be statistically different between group~ at 2 weeks of age. but by 6 week., were similar 10 blood values in adult control animals ( Table 2) .
T he lotal blood volumc sampled duri ng the fi rst wcek after birth wa~ not different between the two groups (3.8 ± 1.2 rnl for AZT infant~ and 4.1 ± 0.8 ml for control infants). 
C. HA ET ttL
TAlltE 2. Ifl'nral% l{ir PO"lIIlflr'1'J ''1 ;"1"'"$ ."",. MCV values \\ere nol ~tati slicall} different between groups I week after binh (AZT-cltposcd. 87.8:!: 5.6 0 :
control. 80.0 ± 6.0 n: I' = .051). Values in both groups declined ~tcadil) with ag~ and reached adul t MeV val -LII!" by 14 weeks of age (Table 2 ). EPO con centralion~ were nOI different belwecn groups llt any age evaluated . Tot:!1 leukocytc increased over the IQ-month sampling pc riod in both group~ and showed no effects of AZT e-.:posurc. ANC, ALC, and plalelet counts also were unaffected by AZT e-.:posure.
Marro" morphology and Ihe percentage of el)throid cell .. also \\cre not affccted 'ignificantl}. The mean percCnlage ± SD of eryth roid eell s wa ... 32'l ± 19%: in AZT· expo ... ed infants and 42'* ± 2511 in control infanh {p :> .5). Nor were there ~isnificant differences in CFU-E. No significllnt differcncc~ were found between control lind AZT o ffspring in ullr:l"ound measurements of head area. biparietal di St:lnce. or femur length. The ratio ... of head circumference to :tbdominal circumference (a meal>ure of intrauterine growth retardation) were not sigmficant I} different hel\\oeen treatment groups. Neither did birth weights differ significantl y bel\\ocen the I .... 0 group~, although weight incrca,e from birth to 300 days wa.... lIignificantl y lo wer in AZT-exposed infanL'i (p < .001: Fig. 4) . Both control and AZT-cx posed animals were above the noml~ for the IPRL nurseI)'. and AZT-expol'ocd infant~ cuught up to the cont rol inf:\nL~ by 2 years of age (Fig. 4) .
BFU-E. or CFU-GM
Analysis of cliniclll record~ ror the first 300 po~tnatal days revealed no significant difference bet\\I..'Cn groups in IIle number of day~ 011 clinical lreallnent. the overall number of lreatmentl'o. or the numher of da ys per treatIlle nt.
AZT-exposed inf:mtl'o were ~ignificanlly delayed in developi ng a rooting rcn ex (Table 3) . They abo sho\\oed ~ig nifi cant delays in vis ually orienting to and tracking ncar objects. differ significantly from control i nfanL~ in age of achieving object concept mile <;tone~. Some statistically significanl d ifferences were revealed by the WGTA Lcaming scries. AZT-exposed infan~ took twice as many sc~sions as cont rol infants to meet criterion on Black· While Learning (AZT: 5.2 sessions. " = 8: control: 2.7 ~essions. n = 6: p = .016). These resu lts werc not due 10 an increased occurrence of refusal-to-panicipate. but seem 10 rcnect real deficiency in the ability to learn the tusks. Thcre were no differences. however, in the number of !>C~s i o n s 10 meet crite- 
DISCUSS ION
Treating Ihese macaques with AZT on a regimen of 1.5 mglkg e\-cry 4 houn; produced plasma concenlmlions si milar 10 those reponed in human subjeeL" that take 500 to 600 mg/day AZT (23) . There wa~ a high degree or variabili ty in pe<lk pla~tlla concentrat ion. bOlh wi thin and bclween subjects. during chron ic AZT treat mcnt. similar 10 thm reponed in human pallenls (23) (24) (25) . We did not. howe vcr. ob~c rvc the decrell.')e in Cn,a~ o r AUC reponed for Ihree women that received 200 mg every 4 hours both before and after de livcry (25) .
AZT concentrations in amniotic fluid were low in the first trimester and increased o\er time with fetal maturit y. most likely due 10 maturmion o f renal excretory runclion . Low concentration'> in amniotic fluid have also been reponed in pregnant women: 83 ng/ml in a woman whose pregn:mcy was tenninatcd at 13 weeks (26) and <50-290 ng/ml in women trellted with 200 mg AZT five times daily (27) . Third·trimcslcr AZT concentrations in our macaques were considerably lowcr than the 875 to 1739 nglml afler 200 mg every 4 hours of oral AZT reponed by WallS et :II. (25) .
All of our AZT·trc:l tcd re males developed an asymptomatic. macrocytic anemi :! lhal di sappeared when AZT wa~ discontinued. Humans and macaques exposed to chronic AZT therapy ~h ow very ~illl ilar patterns o f decli ning hemoglobin level<; with progressively increasi ng MeV (28-30). However. lhe hemato logic tox icity we report here i~ somewhat grealer tha n that fou nd in humans <ltthe equi valent dose range of 500 to 600 mgld3y. Our control animab a l~o showcd a significant decli ne in hemoglobin within the fi r~t month of water treatment. sugge~ting that the blood·sampling regimen contributed to the greater anemia !;Cen in the AZT-trcllled animals. Like HI V subjects treated with 1500 mg/day (29) . ani· mals with the lower baseline hemoglobin levels showed a more significant anemia response to AZT. In pregnant women ITealed with AZT at doses of 500 (3) . 900 (8) . or 1200 mgld:\y (25) . no significant anemia has been reported. However. a progre~sive and ~ignifieant increase in MCV was loccn wi th the higher do"ing regimens: while not reported in pregnant women that receivcd 500 mg. AZT dai ly (3) . significant and per~blent increases in No ... ignilicant change.!. in platelet levels were observed in pregnal11 women who were taking AZT at 500 mglday or at 1000 mglday (34 ). However. in men treated wi lh 1500 rng/day (35), platclcb inerea~ed through wet:k 22 . In thrombocytopenic men being treated with 600 mg/ day. platelet counh were mrn:illl:ltl), e lc .. ated by 9 weck~ and remained elc\ated oler ba.-.cline throughou t the remaining weeks of treatment (7) .
Human IIlfatus that have III utero expo~ure to AZT during the ~econd or third trimcster of pregnancy may be mildly f1nemic at birth but usu;LIly uchieve normal levcl~ within 4 to 6 Ilcek~ withoUl clinical intervention (3.34. 38) . OUf AZT-expo~ed infanb were also mildl) anemic lit binh compilred with control infanl~. The dilTcrem.:e~ I .. ere ~tatistkally significant within the first \Ied: and lasted through 6 \Ieeb of age. similar to tht: pattern ~en in human infan\<'. Thc physiologic anemia in our AZTexposcd infanh reached nadir earlier than in the control infant~. a to. xicity e ffect also ob~c rvcd in human inf:mts (341.
Tht: mean difference, in placental weight seen in our t\\O group~ were likely artifaclU:ll. as a result of the ,mall number of animah ~t u d i ed in each group. r-.1ean placental w~ights reported for pigtailed macaques are 125 g (range. 91 -179 g ) for full -term placentas and 90 g (range. 64-121 gl for ~ho rt-gcq'l t i on placenta~, defined as 11510161 da)s (39) . The pla(;~nta l weigh~ reported here for CONT-P and colol1) animab arc comparable with thosc of full -Icnn placentas. However. the placental wc i ght~ of the AZT -P animab arc closer to shortge>;tation weighls. Male infants have been repon~d to haw stlltistically signific;llItly heavier placent;] 1 weights than females (39), but we did not collect t:nough placenlas to detect difrcrcnce~ related to gender. At·tually. the quantities of blood trapped wi thin the placenta at Jelivcry are ~o variable that Fox (40) questioned the ability to adequately dCternline placental mass. Although the range of human birth weights for a given placental weight is very large (41) . heavier placentas arc generally as~oci· ated with heavier infams at birth. We found no statbtically significant difference~ in the ratio of placental weight to infant birth weight in our two study groups.
Our prenatal and postnatal growth data renect the f:lct that infants in both treatment and control group~ wen:
largc: birth weighb were not different bet .... een the twO groups but a\erdged in the 79th percentile whell compared with norms at the Wa~hing ton RPRC: 9 of the 16 infants \\.ere Ol'er the 90th percenti le. We hypothcsil.c that thi~ large fetal and ncomltal ~i /e may be an elTcct of the tethering !'y~teLll . The lowe r growth increase in AZTexpo~ed animal~ is likely explained by the early anemia noted in infanK Lilewise. we believe that the signific:mt effects o f AZT exposure on rooting and snouting renexes may reneet early failure to thri .. c due to anemia. Deficiencies in the abi lity to orient to and follow near !>Iimuli visually. which dcvelop~ at a you nger Ilge than orienting to di~tant ~timuli. may al~o renect the efrecL~ of ancm;rt on the development of the retinal sy~tem (42). We cannot olTer a ~ati~f3Ctory explanation for the delay in ;;imple di<i-crimination learning e.xhibitcd b) AZT·e:«po~ed infant~. Except for the , ingle in(;iucnce of hepatocellular :lIro· phy in the dam with transient ,c"ere neutropenia and the severe hematologic toxic;t) in the hydropic fetus. the clinically rclcv!lm mmemal. ft:tal lmd infant IOxicitic~ reported here lire ~imil'lr to tho~e reponed for pregnant women who began taking AZT in the ~cond or third trimestt:r. A, these ~ingle toxi~' ili e, wcre not reproducible. we conclud\." Ihm they wt're probably unrelated to AZT therapy or. ir related. only at a low frequency.
In summary. we believe the pigtailed macaque is an effective model for the study of feta l and infant toxicity of anli-I II Y drug~. Because the dam~ and off~pring di~ played toxicities comparable to tho-.e observed in hu· man,. we expect that the fetal/infant growth and dc\cl· opmcnt measures reponed here ~holLld also be cornparable wil h those of human inf:ulIs exposcd 10 AZT in utero. Earlier treatment (firsttrit1le~la) with AZT in humam may further reduce the probability of miLternalfet:ll transmis"ion. Such treatment ha~ not been advocated owing to concerns about exposing the fetu s at a time when ;1 i~ most su~ceptib l e to drug toxicity. Because our sample si7.es were relatively ~mall. we wou ld have the power 10 detect onl y a relatively high incidence o f adverse CffCCL\. However, on the ba!ois of our data we would predict that carly cxpo~ure 10 AZT in utero ~houJd
